Reuters - Video

Edition: US | UK | IN | CN | JP

video Business

Drugmakers in spotlight as GSK recalls Zantac

Wednesday, October 09, 2019 - 01:19

Drugmakers were in the spotlight Wednesday as GSK recalls Zantac after U.S. regulators found probable cancer-causing impurities in the drug. Also in the U.S.: a jury says Johnson & Johnson must pay $8 billion in a case over male breast growth linked to Risperdal. David Pollard reports.

▲ Hide Transcript

View Transcript

Drugmakers were in the spotlight Wednesday as GSK recalls Zantac after U.S. regulators found probable cancer-causing impurities in the drug. Also in the U.S.: a jury says Johnson & Johnson must pay $8 billion in a case over male breast growth linked to Risperdal. David Pollard reports.

Press CTRL+C (Windows), CMD+C (Mac), or long-press the URL below on your mobile device to copy the code

Drugmakers in spotlight as GSK recalls Zantac

Wednesday, October 09, 2019 - 01:19